|
Cours en clôture
18/09/2026
|
Varia. 5j.
|
Varia. 1 janv.
|
|
45,55 CNY
|
+0,82%
|
 |
+1,11%
|
-5,83%
|
|
28/08 |
Shanghai Rendu Biotechnology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026
| | |
14/05 |
Shanghai Rendu Biotechnology's share trade to resume from May 15
| | |
14/05 |
Nanjing Haijing Pharmaceutical Co., Ltd. agreed to acquire 21.25% stake in Shanghai Rendu Biotechnology Co., Ltd. from Ju Jinliang, Qiming Weichuang Venture Capital Management Company Limited, Runcong Enterprise Management Center (Limited Partnership), China International Capital Corporation Limited, Qiming Ventures Fund III, Changzhou Jinxin Venture Capital Co., Ltd. and Novel Praise Limited for approximately CNY 520 million.
| | |
08/05 |
Rendu Biotech's Controlling Shareholder Eyes Share Transfer Deal
| | |
07/05 |
Trading in Shanghai Rendu Biotechnology's shares to halt
| | |
28/04 |
Shanghai Rendu Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026
| | |
27/02 |
Shanghai Rendu Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025
| | |
30/10/25 |
Shanghai Rendu Biotechnology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025
| | |
29/08/25 |
Shanghai Rendu Biotechnology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025
| | |
29/04/25 |
Shanghai Rendu Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2025
| | |
27/02/25 |
Shanghai Rendu Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2024
| | |
29/10/24 |
Shanghai Rendu Biotechnology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2024
| | |
29/08/24 |
Shanghai Rendu Biotechnology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2024
| | |
20/08/24 |
Tranche Update on Shanghai Rendu Biotechnology Co., Ltd.'s Equity Buyback Plan announced on February 19, 2024.
| | |
16/08/24 |
Shanghai Rendu Biotechnology Co., Ltd.'s Equity Buyback announced on February 19, 2024, has closed with 1,291,428 shares, representing 3.23% for CNY 35.65 million.
| | |
02/07/24 |
Tranche Update on Shanghai Rendu Biotechnology Co., Ltd.'s Equity Buyback Plan announced on February 19, 2024.
| | |
29/04/24 |
Shanghai Rendu Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
| | |
02/04/24 |
Tranche Update on Shanghai Rendu Biotechnology Co., Ltd.'s Equity Buyback Plan announced on February 19, 2024.
| | |
27/02/24 |
Shanghai Rendu Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
| | |
19/02/24 |
Shanghai Rendu Biotechnology Co., Ltd. announces an Equity Buyback for CNY 50 million worth of its shares.
| | |
18/02/24 |
Shanghai Rendu Biotechnology Co., Ltd. authorizes a Buyback Plan.
| | |
30/10/23 |
Shanghai Rendu Biotechnology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
| | |
31/07/23 |
Shanghai Rendu Biotechnology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
| | |
21/06/23 |
Shanghai Rendu Biotechnology Gets Certificate for Registration of HIV Kit
| | |
25/04/23 |
Shanghai Rendu Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
| |
Aucun résultat pour cette recherche Sélectionnez votre édition Toutes les informations financières adaptées au niveau national | 
